Showing results (151-160 of 1,902) with videos related to

Sort By:
Pageof 191
Leukemia & Lymphoma|April 11, 2003
Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemiaM J Keating, S O'Brien, D Kontoyiannis, et al.
Blood|January 1, 1993
Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2'-deoxyadenosine and 9-beta-D-arabinosyl-2-fluoroadenineL E Robertson, S Chubb, R E Meyn, et al.
Dermatology (Basel, Switzerland)|April 9, 2002
Diagnostic features of pemphigus vulgaris in patients with bullous pemphigoid. Molecular analysis of autoantibody profileNaveed Sami, Kailash C Bhol, Ernst H Beutner, et al.
Cancer Research|January 19, 1999
Enhancement of tumor radioresponse in vivo by gemcitabineL Milas, T Fujii, N Hunter, et al.
Biochemical Pharmacology|October 15, 1982
Aspartate carbamoyltransferase activity, drug concentrations, and pyrimidine nucleotides in tissue from patients treated with N-(phosphonacetyl)-L-aspartateE C Moore, J Friedman, M Valdivieso, et al.
Molecular Pharmacology|October 1, 1990
Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2',2'-difluorodeoxycytidineV Heinemann, Y Z Xu, S Chubb, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Natural killer cell activity in chronic lymphocytic leukemia patients treated with fludarabineL E Robertson, A W Denny, Y O Huh, et al.
Cancer Research|June 1, 1987
Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapyW Plunkett, J O Liliemark, T M Adams, et al.
Blood|June 1, 1993
Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agentM J Keating, S O'Brien, H Kantarjian, et al.
Molecular Pharmacology|March 1, 1992
Membrane-permeable dideoxyuridine 5'-monophosphate analogue inhibits human immunodeficiency virus infectionJ K Sastry, P N Nehete, S Khan, et al.
Pageof 191